Localization and Quantitation of Eotaxin mRNA in Human Nasal Polyps

References

• Molecular Diagnostics for the Clinical Laboratorian, W. B. Coleman, G. T. Tsongalis. Humana Press, Totowa, NJ 1997
   Google Scholar
• Non‐infective inflammatory conditions. Ear, Nose and Throat Histopathology2nd ed., L. Michaels, H. Hellquist. Springer, London 2000
   Google Scholar
• Alam R. Chemokines in the biology of cell movement and inflammation. Allergy: Principles and Practice5th ed., E. Middleton. Mosby, St. Louis, MO 1998; 124
   Google Scholar
• Allen J. S., Eisma R., LaFreniere D., Leonard G., Kreutzer D. Characterization of the eosinophil chemokine RANTES in nasal polyps. Ann. Otol., Rhinol., Laryngol. 1998; 107(5 Pt 1)416–420
   PubMedGoogle Scholar
• Bachert C., Wagenmann M., Rudack C., Hopken K., Hillebrandt M., Wang D., van Cauwenberge P. The role of cytokines in infectious sinusitis and nasal polyposis. Allergy 1998; 53(1)2–13
   PubMedGoogle Scholar
• Bachert C., Gavaert P., Holtappels G., Cuvelier C., van Cauwenberge P. Nasal polyposis: from cytokines to growth. Am. J. Rhinol. 2000; 14(5)279–290
   PubMedGoogle Scholar
• Bachert C., Gevaert P., Holtappels G., Johansson S. G., van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J. Allergy Clin. Immunol. 2001; 107(4)607–614
   PubMed Web of Science ®Google Scholar
• Bernstein J. M. The molecular biology of nasal polyposis. Curr. Allergy Asthma Rep. 2001; 1(3)262–267
   PubMedGoogle Scholar
• Bernstein J. M., Gorfien J., Noble B., Yankaskas J. R. Nasal polyposis: immunohistochemistry and bioelectrical findings (a hypothesis for the development of nasal polyps) [Clinical Aspect Of Allergic Disease]. J. Allergy Clin. Immunol. 1997; 99(2)165–175
   PubMed Web of Science ®Google Scholar
• Caversaccio M., Hartnell A., Calnan D., Jose P., Mackay I. S., Uguccioni M., Baggiolini M., Williams T. J., Conroy D. M. The role of chemokines in nasal polyps. Schweizerische medizinische wochenschrift. J. Suisse Med. 2000; 125: 92S–95S
   Google Scholar
• Chomczynski P., Sacchi N. Isolation of RNA by the single‐step acid guanidinium thiocyanate‐phenol‐chloroform extraction method. Anal. Biochem. 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Chung K. F., Patel H. J., Fadlon E. J., Rousell J., Haddad E.‐B., Jose P. J., Mitchell J., Belvisi M. Induction of eotaxin expression and release from human airway smooth muscle cells by IL‐1β and TNF‐α: effects of IL‐10 and corticosteroids. Br. J. Pharmacol. 1999; 127(5)1145–1150
   PubMedGoogle Scholar
• Frieri M. Corticosteroid effects on cytokines and chemokines. Allergy Asthma Proc. 1999; 20: 147–159
   PubMedGoogle Scholar
• Graziano F. M., Cook E. B., Stahl J. L. Cytokines, chemokines, RANTES, and eotaxin. Allergy Asthma Proc. 1999; 20(3)141–146
   PubMedGoogle Scholar
• Han S. J., Kim J. H., Noh Y. J., Chang H. S., Kim C. S., Kim K.‐S., Ki S. Y., Park C. S., Chung I. Y. Interleukin (IL)‐5 downregulates tumor necrosis factor (TNF)—induced eotaxin messenger RNA (mRNA) expression in eosinophils. Am. J. Respir. Cell Mol. Biol. 1999; 21: 303–310
   PubMedGoogle Scholar
• Holmberg K., Karlsson G. Nasal polyps: medical or surgical management?. Clin. Exp. Allergy 1996; 26(3)23–30
   PubMedGoogle Scholar
• Jahnsen F. L., Haye R., Gran E., Brandtzaeg P., Johansen F. E. Glucocorticoids inhibit mRNA expression for eotaxin, eotaxin‐2, and monocytes‐chemotactic protein‐4 in human airway inflammation with eosinophilia. J. Immunol. 1999; 163(3)1545–1551
   PubMedGoogle Scholar
• Kay A. B., Meng Q., Robinson D. S., Zeibecoglou K., Humbert M., Ying S. Phenotype of cells expressing eotaxin, eotaxin‐2, MCP‐r, MCP‐3 and RANTES in bronchial mucosa. Comparison of atopic asthmatics and non‐atopic asthmatics. J. Allergy Clin. Immunol. 2000; 105: S147
   Google Scholar
• Koury S. T., Bondurant M. C., Koury M. J. Localization of erythropoetin synthesizing cells in murine kidneys by in situ hybridization. Blood 1988; 71: 524
   PubMed Web of Science ®Google Scholar
• Lamblin C., Bolard F., Gosset P., Tsicopoulos A., Perez T., Darras J., Janin A., Tonnel A. B., Hamid Q., Wallaert B. Bronchial interleukin‐5 and eotaxin expression in nasal polyposis. Relationship with (A)symptomatic bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 2001; 163(5)1226–1232
   PubMedGoogle Scholar
• Maune S., Pods R., Bartels J., Schroder J.‐M. Nasal fibroblasts express eotaxin mRNA. Allergologie 1999; 22: 477–480
   Google Scholar
• Mygind N., Dahl R., Bachert C. Nasal Polyposis, eosinophil dominated inflammation and allergy. Thorax 2000; 55(Supp 2)S79–S83
   Google Scholar
• Nonaka M., Pawankar R., Saji F., Yagi T. Eotaxin synthesis by nasal polyp fibroblasts. Acta Oto‐Laryngol. 1999; 119(7)816–820
   PubMed Web of Science ®Google Scholar
• Oxvig C., Gleich G. J., Sottrup‐Jensen L. Localization of disulfide bridges and free sulfhydryl groups in human eosinophil granule major basic protein. FEBS Lett. 1994; 341: 213–217
   PubMedGoogle Scholar
• Pullerits T., Linden A., Praks L., Cardell L. O., Lotvall J. Upregulation of nasal mucosal eotaxin in patients with allergic rhinitis during grass pollen season: effect of a local glucocorticoid. Clin. Exp. Allergy 2000; 30: 1469–1475
   PubMedGoogle Scholar
• Shahabuddin S., Ponath P., Schleimer R. P. Migration of eosinophils across endothelial cell monolayers: interactions among IL‐5, endothelial‐activating cytokines, and C–C chemokines. J. Immunol. 2000; 164(7)3847–3854
   PubMedGoogle Scholar
• Shin S. H., Park J. Y., Jeon C. H., Choi J. K., Lee S. H. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils. Laryngoscope 2000; 110(8)1353–1357
   PubMedGoogle Scholar
• Slavin R. G. Nasal polyps and sinusitis. Allergy: Principles and Practice5th ed., E. Middleton. Mosby, St. Louis, MO 1998
   Google Scholar
• Stoop A. E., van der Heijden H. A., Biewenga J., Vandarbaan S. Eosinophils in nasal polyps in nasal mucosa: an immunohistochemical study. J. Allergy Clin. Immunol. 1993; 91: 616–622
   PubMed Web of Science ®Google Scholar
• Terada N., Hamano N., Nomura T., Numata T., Hirai K., Nakajima T., Yamada H., Yoshie O., Ikeda‐Ito T., Konno A. Interleukin‐13 and tumor necrosis factor—α synergistically induce eotaxin production in human nasal fibroblasts. Clin. Exp. Allergy 2000; 30: 348–355
   PubMedGoogle Scholar
• Thomsen A. R., Sottrup‐Jensen L., Gleich G. J., Oxvig C. The status of half‐cysteine residues and locations of N‐glycosylated asparagine residues in human eosinophil peroxidase. Arch. Biochem. Biophys. 2000; 379: 147–152
   PubMedGoogle Scholar
• Ying S., Robinson D. S., Meng Q., Rottman J., Kennedy R., Ringler D., Mackay C., Daugherty B., Williams T. J., Durham S. R., Kay A. B. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial cells and endothelial cells. J. Allergy Clin. Immunol. 1998; 101: S41
   Google Scholar